Related Experiment Video
Updated: Jun 15, 2026

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Species differences in pharmacokinetics and pharmacodynamics
Pierre-Louis Toutain1, Aude Ferran, Alain Bousquet-Mélou
1Unité Mixte de Recherche 181 Physiopathologie et Toxicologie Expérimentales, Institut National de la Recherche Agronomique et Ecole Nationale Vétérinaire de Toulouse, 23 Chemin des Capelles, BP 87 614, 31076 Toulouse Cedex 03, France. pl.toutain@envt.fr
Veterinary drug dosing requires careful consideration of species-specific pharmacokinetics and pharmacodynamics. Understanding these differences is crucial for effective and safe animal treatment, as generalizations are often unreliable.
Area of Science:
- Veterinary Pharmacology
- Comparative Physiology
- Animal Health
Background:
- Veterinary medicine treats diverse species with unique genetic traits and physiological differences.
- Determining rational drug dosing regimens is a significant challenge due to inter- and intra-species variations.
- Drug response variability stems from differences in pharmacokinetics (PK) and pharmacodynamics (PD).
Purpose of the Study:
- To highlight key species differences in drug PK and PD within domestic animals.
- To explore the physiological, patho-physiological, and behavioral mechanisms underlying these differences.
- To emphasize the need for species-specific drug evaluation.
Main Methods:
- Review of selected aspects of PK and PD across domestic animal species.
- Analysis of physiological, patho-physiological, and behavioral determinants of drug response.
- Consideration of drug administration modalities and management options.
Main Results:
- Significant interspecies differences in drug absorption, distribution, metabolism, and elimination (ADME) were observed, particularly related to digestive functions.
- Interspecies variations in drug action (PD) are generally less pronounced, except in specialized functions like reproduction.
- Drug metabolism is a major contributor to PK and PD variability, including the formation of active metabolites.
Conclusions:
- Species differences in drug handling and response are numerous, often unpredictable, and preclude broad generalizations.
- Allometric approaches offer some predictive value for interspecies drug extrapolation.
- Each drug requires individual evaluation for each species to ensure efficacy, safety, animal well-being, and protection of the food chain and environment.
More Related Videos
08:59An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Pharmacogenetics of Drug Metabolism: Overview
Pharmacodynamic Responses: Different Types
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...